Gary, I agree very strongly with you in these points. I think traders and those lookin to feel rich much sooner than might happen here yet, will disagree. But long-term, in terms of the creation of and retention of potential value long-term, to long-term holders, I think she is doing exactly what is best.
Just my viewpoint, but I know there are others, like you, who also agree. It is rare that biotechs attempt to do this, but I believe she has had complete confidence in DCVax, beyond the confidence that most CEO’s of these tiny biotechs typically has in the venture.